Jubilant Pharmova Limited

Web: jubl.com NSE: JUBLPHARMA BSE: 530019 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

912 4(0%)

Volume

1L as on 03, Sep

Open

1,206

High

1,096

Low

1,068

908

VWAP

903

52 Week High

1,185

52 Week Low

786

Viand Research Rating

Quality Score

10/100

Growth Score

67/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

14,526

No. of Shares

15.9

P/E

622.93

P/B

8.24

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

1.32

ROCE

Profit Growth

Listing Date

16-Jun-03

Promoter Holding

47.67%

FII Holding

15.9%

DII Holding

11.63%

Price Chart

Price Performance

1 Week3%

1 Month3%

3 Months7%

6 Months7%

1 Year15%

YTD14%

Moving Average

5 Day SMA896

10 Day SMA893

20 Day SMA895

30 Day SMA913

50 Day SMA942

61 Day SMA947

80 Day SMA958

200 Day SMA963

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	928	905	920	932
Resistance 2	920	904	913	922
Resistance 1	910	902	909	914
Pivot Point	902	900	902	904
Support 1	892	899	895	896
Support 2	884	897	891	886
Support 3	874	895	884	878

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 47.67%	(0.01) 47.67%	(0.01) 47.67%	(-3.01) 47.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.67%	(0.01) 50.68%	(0.01) 50.68%	(0.01) 50.68%	(0.01) 50.68%
FIIs	(-0.11) 15.90%	(-0.61) 15.96%	(-0.81) 16.56%	(0.21) 17.40%	(0.31) 17.23%	(-1.01) 16.96%	(-1.61) 17.94%	(0.41) 19.50%	(-1.21) 19.06%	(-2.91) 20.29%	(0.01) 23.20%	(0.01) 23.20%	(-0.21) 23.22%	(0.31) 23.38%	(-0.41) 23.06%	(0.01) 23.47%	(0.31) 23.45%	(0.01) 23.18%	(0.01) 23.14%
DIIs	(0.41) 11.63%	(0.71) 11.23%	(1.01) 10.53%	(2.51) 9.52%	(0.11) 7.05%	(1.31) 6.99%	(1.61) 5.66%	(0.31) 4.06%	(0.91) 3.77%	(1.31) 2.89%	(0.01) 1.64%	(0.01) 1.63%	(0.01) 1.62%	(0.01) 1.62%	(1.01) 1.60%	(0.01) 0.62%	(-0.41) 0.63%	(0.01) 1.06%	(0.01) 1.03%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.24%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	24.25%	24.57%	24.60%	24.83%	24.48%	24.82%	25.17%	25.18%	25.91%	25.56%	23.89%	23.91%	23.11%	24.20%	24.59%	25.17%	25.18%	25.01%	25.09%
No. of Shareholders	86,347	90,133	93,336	99,673	96,526	102,442	89,456	81,992	92,264	86,588	89,376	93,375	97,935	100,212	105,632	109,410	108,063	109,420	113,776

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	2290	2122	1966	1901	1929	1822	1752	1732	1759	1677	1680	1587	1678	1552	1600	1452	1528	1311	1657	1635
Sales Growth % (YoY)	-	16.5%	12.2%	9.8%	9.7%	8.6%	4.3%	9.1%	4.8%	8%	5%	9.3%	9.8%	18.5%	-3.5%	-11.2%	-3.3%	-26%	4.2%	41.4%
Sales Growth % (QoQ)	7.9%	7.9%	3.4%	-1.5%	5.9%	4%	1.2%	-1.5%	4.9%	-0.2%	5.9%	-5.4%	8.1%	-3%	10.2%	-5%	16.6%	-20.9%	1.3%	-
Expenses	1951	1833	1625	1611	1584	1535	1463	1480	1487	1459	1438	1419	1459	1408	1384	1259	1280	1116	1319	1269
Operating Profit	339	289	341	290	345	287	289	252	271	218	242	168	219	144	216	192	247	194	338	365
OPM %	15	14	17	15	18	16	17	15	15	13	14	11	13	9	14	13	16	15	20	22
Other Income	10	-19	4	12	9	-10	8	410	-151	49	19	9	21	10	-44	11	-2	6	4	4
Interest	56	56	50	49	53	56	61	71	73	71	66	62	56	51	42	40	40	37	35	35
Depreciation	117	121	105	98	95	91	91	91	101	95	97	90	271	94	94	95	101	93	100	88
Profit before tax	176	93	190	154	206	130	144	500	-54	101	98	25	-86	9	36	69	106	70	208	247
Tax %	32	40	37	34	27	23	29	4	15	34	37	76	16	285	87	32	44	28	31	35
Net Profit	119	56	120	102	151	101	102	482	-62	66	62	6	-100	-16	5	47	59	51	143	160
Net Profit Growth % (QoQ)	112.5%	-53.3%	17.6%	-32.5%	49.5%	-1%	-78.8%	877.4%	-193.9%	6.5%	933.3%	106%	-525%	-420%	-89.4%	-20.3%	15.7%	-64.3%	-10.6%	-
Net Profit Growth % (YoY)	-21.2%	-44.6%	17.6%	-78.8%	343.5%	53%	64.5%	7933.3%	38%	512.5%	1140%	-87.2%	-269.5%	-131.4%	-96.5%	-70.6%	-	-	-	-
TTM Net Profit	397	429	474	456	836	623	588	548	72	34	-48	-105	-64	95	162	300	413	354	303	0
EPS in Rs	7.5	3.51	7.55	6.46	9.64	6.33	6.45	30.26	-3.68	4.19	3.92	0.4	-6.15	-0.98	0.34	2.96	3.74	3.2	8.97	10.08

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	8280	7234	6703	6282	6130	6099	5976	9111	7518	5861	5749	5751	5762	5132
Sales Growth %	14.4%	7.9%	6.7%	2.5%	0.5%	2%	-34.4%	21.2%	28.3%	2%	0%	-0.2%	12.3%	20.2%
Expenses	7020	6061	5802	5503	4980	4695	4428	7367	5995	4510	4493	5141	4763	4134
Operating Profit	1260	1173	901	779	1150	1403	1548	1744	1522	1352	1256	610	999	999
OPM %	15	16	13	12	19	23	26	19	20	23	22	11	17	19
Other Income	7	416	-76	-9	8	263	225	-249	36	19	4	86	-173	-93
Interest	212	240	272	188	145	184	200	220	284	341	371	368	337	311
Depreciation	440	369	382	554	382	349	340	371	415	291	347	288	281	254
Profit before tax	614	981	170	28	630	1133	1233	904	859	738	542	40	207	341
Tax %	35	15	57	333	34	26	27	36	26	22	29	200	34	45
Net Profit	398	836	73	-65	413	836	898	577	634	575	387	-40	138	189
Net Profit Growth %	-52.4%	1045.2%	212.3%	-115.7%	-50.6%	-6.9%	55.6%	-9%	10.3%	48.6%	1067.5%	-129%	-27%	-
EPS in Rs	25.02	52.69	4.84	-3.83	25.98	52.47	56.39	36.06	40.35	36.14	24.6	-3.63	6.84	9.59
Dividend Payout %	20	9	102	-130	19	10	9	12	7	8	12	-83	43	31

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	1072	971	661	838	1784	1543	1122	1303	1268	1099	783	772	970
Cash from Investing Activity	512	-596	-474	-323	-727	-267	-1018	-614	-465	-309	-362	-164	-504
Cash from Financing Activity	-1453	-432	-157	-33	-1709	-1050	657	-901	-686	-843	-503	-414	-450
Net Cash Flow	132	-58	30	482	-652	225	761	-212	117	-52	-82	194	17

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	16	16	16	16	16	16	16	16	16	16	16	16	16	16	15	16
Reserves	7077	6576	6239	5925	5418	5383	5303	4726	5588	4793	4071	3420	2951	2438	2611	2460
Borrowings	3615	2883	2731	3080	3664	3677	3192	2830	4808	4840	3469	4045	4493	4793	4395	4245
Other Liabilities	4815	4047	3598	2904	2240	1853	1319	1192	1898	1670	1902	1417	1280	1372	1842	1650
Total Liabilities	15523	13521	12584	11924	11338	10929	9830	8763	12310	11319	9457	8899	8740	8619	8864	8371
Fixed Assets	8044	7354	5176	5962	5091	5183	4871	4609	6340	5648	5401	5107	5104	4911	5099	4967
CWIP	2962	2344	3630	1857	2103	1562	1090	897	768	901	671	684	611	597	472	437
Investments	61	45	44	42	42	256	239	241	69	115	124	103	85	40	34	26
Other Assets	4455	3778	3735	4063	4101	3928	3631	3017	5133	4654	3262	3006	2939	3071	3259	2941
Total Assets	15523	13521	12584	11924	11338	10929	9830	8763	12310	11319	9457	8899	8740	8619	8864	8371

Delivery

Delivery Data: JUBLPHARMA

#	Date	848 23% 1042	Value (Cr)	Q/T 14	Del 55	Del 32
1	4-Sep	924	46	18	43	20
2	3-Sep	908	11	8	52	6
3	2-Sep	900	6	7	50	3
4	1-Sep	908	28	14	49	14
5	31-Aug	882	20	15	51	10
6	28-Aug	883	11	10	43	5
7	27-Aug	879	8	7	54	4
8	26-Aug	887	10	13	60	6
9	25-Aug	897	17	14	38	7
10	24-Aug	903	174	22	35	61
11	21-Aug	880	20	16	55	11
12	20-Aug	871	16	10	52	8
13	19-Aug	868	82	19	75	62
14	18-Aug	866	15	11	58	9
15	17-Aug	867	27	11	49	13
16	14-Aug	866	19	11	58	11
17	13-Aug	890	19	15	42	8
18	12-Aug	891	63	18	39	24
19	11-Aug	965	83	12	35	29
20	10-Aug	963	34	12	56	19
21	7-Aug	932	16	15	54	8
22	6-Aug	926	15	9	65	10
23	5-Aug	925	7	12	54	4
24	4-Aug	933	5	9	57	3
25	3-Aug	933	19	10	58	11
26	31-Jul	935	21	12	61	13
27	30-Jul	962	7	8	56	4
28	29-Jul	977	12	13	65	8
29	28-Jul	963	12	8	58	7
30	27-Jul	980	12	9	59	7
31	24-Jul	965	5	11	43	2
32	23-Jul	971	7	11	46	3
33	22-Jul	989	11	9	47	5
34	21-Jul	1008	7	6	51	4
35	20-Jul	1024	8	10	49	4
36	17-Jul	1023	11	9	44	5
37	16-Jul	1021	29	12	45	13
38	15-Jul	1028	72	17	36	26
39	14-Jul	974	5	5	50	3
40	13-Jul	973	14	10	56	8
41	10-Jul	964	11	10	55	6
42	9-Jul	969	10	14	59	6
43	8-Jul	971	6	9	40	2
44	7-Jul	979	10	8	50	5
45	6-Jul	982	9	13	49	5
46	3-Jul	969	8	12	62	5
47	2-Jul	973	5	10	53	3
48	1-Jul	976	9	9	48	4
49	30-Jun	971	19	16	58	11
50	29-Jun	954	5	8	40	2

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	14,526c	74c	0.51
03-Sep	14,452c	507c	3.63
01-Sep	13,945c	50c	0.36
31-Aug	13,895c	112c	0.80
27-Aug	14,006c	425c	2.95
26-Aug	14,432c	160c	1.12
25-Aug	14,272c	127c	0.88
24-Aug	14,399c	490c	3.52
21-Aug	13,909c	100c	0.72
19-Aug	13,810c	46c	0.34
18-Aug	13,764c	10c	0.07
17-Aug	13,773c	43c	0.31
14-Aug	13,730c	457c	3.22
13-Aug	14,187c	139c	0.99
12-Aug	14,049c	1,242c	8.13
11-Aug	15,291c	0	0
10-Aug	15,291c	497c	3.36
06-Aug	14,794c	37c	0.25
05-Aug	14,831c	22c	0.14
04-Aug	14,852c	13c	0.09
03-Aug	14,865c	92c	0.61
31-Jul	14,957c	462c	3.00
30-Jul	15,418c	247c	1.58
29-Jul	15,665c	296c	1.92
28-Jul	15,370c	138c	0.89
27-Jul	15,508c	0	0

Stock Checklist

Price is above from 52 week high low average: 32%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 95 fund scheme(s) across 22 fund house(s) as of Aug26 · Total value ₹2,657 Cr · 9 increasing / 51 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	12	1.51%	+0.19%	996
Kotak Mahindra Mutual Fund	14	0.83%	-0.23%	675.4
quant Mutual Fund	2	0.81%	-0.09%	551.2
HDFC Mutual Fund	10	0.53%	-0.08%	159.1
Aditya Birla Sun Life Mutual Fund	6	0.76%	-0.13%	125.1
Abakkus Mutual Fund	2	1.40%	+1.40%	41.7
Nippon India Mutual Fund	4	0.33%	-0.02%	25.7
Tata Mutual Fund	2	0.83%	+0.47%	25.5
UTI Mutual Fund	4	0.58%	-0.12%	17
SBI Mutual Fund	4	0.25%	-0.02%	12.6
Motilal Oswal Mutual Fund	6	0.13%	-0.02%	11.1
Bajaj Finserv Mutual Fund	2	0.87%	-0.09%	6.5
ICICI Prudential Mutual Fund	4	0.31%	-0.02%	5.4
Edelweiss Mutual Fund	2	0.35%	-0.04%	1.8
Jio BlackRock Mutual Fund	2	0.27%	-0.01%	1.5
Groww Mutual Fund	4	0.12%	-0.02%	1.2
Axis Mutual Fund	2	0.04%	-	0.2
DSP Mutual Fund	4	0.20%	-0.02%	0.1
Navi Mutual Fund	4	0.08%	-0.01%	0.1
Angel One Mutual Fund	2	0.03%	-	0
Mirae Asset Mutual Fund	2	0.04%	-	0
Zerodha Mutual Fund	1	0.20%	-	0

Jubilant Pharmova Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements